Preliminary Clinical Experience with Cholecystokinin-2 Receptor PET/CT Using the<sup>68</sup>Ga-Labeled Minigastrin Analog DOTA-MGS5 in Patients with Medullary Thyroid Cancer

Preliminary Clinical Experience with Cholecystokinin-2 Receptor PET/CT Using the<sup>68</sup>Ga-Labeled Minigastrin Analog DOTA-MGS5 in Patients with Medullary Thyroid Cancer

PET/CT with the new <sup>68</sup>Ga-labeled minigastrin analog DOTA-dGlu-Ala-Tyr-Gly-Trp-(<i>N</i>-Me)Nle-Asp-1-Nal-NH<sub>2</sub> (<sup>68</sup>Ga-DOTA-MGS5) was performed on patients with advanced medullary thyroid cancer (MTC) to evaluate cholecysto...

Uloženo v:

Podrobná bibliografie
Hlavní autoři:	Elisabeth von Guggenberg, Christian Uprimny, Maximilian Klinger, Boris Warwitz, Anna Sviridenko, Steffen Bayerschmidt, Gianpaolo di Santo, Irene Virgolini
Médium:	Artigo
Jazyk:	angličtina
Vydáno:	2023
On-line přístup:	https://doi.org/10.2967/jnumed.122.264977 https://jnm.snmjournals.org/content/jnumed/64/6/859.full.pdf
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky

Automated Synthesis of (68)Ga-Labeled DOTA-MGS8 and Preclinical Characterization of Cholecystokinin-2 Receptor Targeting
Autor: Hörmann, Anton Amadeus, a další
Vydáno: (2022)

Radiopharmaceutical Formulation and Preclinical Testing of (68)Ga-Labeled DOTA-MGS5 for the Regulatory Approval of a First Exploratory Clinical Trial
Autor: Hörmann, Anton A., a další
Vydáno: (2021)

Preclinical Evaluation of (68)Ga-DOTA-Minigastrin for the Detection of Cholecystokinin-2/Gastrin Receptor–Positive Tumors
Autor: Brom, Maarten, a další
Vydáno: (2011)

<sup>68</sup>Ga-DOTA-Tyr<sup>3</sup>-Octreotide PET for Assessing Response to Somatostatin-Receptor–Mediated Radionuclide Therapy
Autor: Michael Gabriel, a další
Vydáno: (2009)

Bone Metastases in Patients with Neuroendocrine Tumor: <sup>68</sup>Ga-DOTA-Tyr<sup>3</sup>-Octreotide PET in Comparison to CT and Bone Scintigraphy
Autor: Daniel Putzer, a další
Vydáno: (2009)

DOTA-MGS5, a New Cholecystokinin-2 Receptor-Targeting Peptide Analog with an Optimized Targeting Profile for Theranostic Use
Autor: Klingler, Maximilian, a další
Vydáno: (2019)

DOTA-MGS5, a New Cholecystokinin-2 Receptor-Targeting Peptide Analog with an Optimized Targeting Profile for Theranostic Use
Autor: Maximilian Klingler, a další
Vydáno: (2018)

68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT
Autor: Michael Gabriel, a další
Vydáno: (2007)

Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine: a clarification
Autor: Alexander Kroiss, a další
Vydáno: (2012)

Targeting of the Cholecystokinin-2 Receptor with the Minigastrin Analog <sup>177</sup>Lu-DOTA-PP-F11N: Does the Use of Protease Inhibitors Further Improve In Vivo Distribution?
Autor: Alexander Sauter, a další
Vydáno: (2018)

Current knowledge on the sensitivity of the (68)Ga-somatostatin receptor positron emission tomography and the SUV(max) reference range for management of pancreatic neuroendocrine tumours
Autor: Virgolini, Irene, a další
Vydáno: (2016)

Direct comparison of (68)Ga-DOTA-TOC and (18)F-FDG PET/CT in the follow-up of patients with neuroendocrine tumour treated with the first full peptide receptor radionuclide therapy cycle
Autor: Nilica, Bernhard, a další
Vydáno: (2016)

Direct comparison of 68Ga-DOTA-TOC and 18F-FDG PET/CT in the follow-up of patients with neuroendocrine tumour treated with the first full peptide receptor radionuclide therapy cycle
Autor: Bernhard Nilica, a další
Vydáno: (2016)

Early Injection of Furosemide Increases Detection Rate of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for (68)Ga-PSMA-11 PET/CT
Autor: Uprimny, Christian, a další
Vydáno: (2021)

The Search for an Alternative to [<sup>68</sup>Ga]Ga-DOTA-TATE in Neuroendocrine Tumor Theranostics: Current State of <sup>18</sup>F-labeled Somatostatin Analog Development
Autor: Christopher M. Waldmann, a další
Vydáno: (2019)

Head-to-Head Comparison of <sup>68</sup>Ga-DOTA-JR11 and <sup>68</sup>Ga-DOTATATE PET/CT in Patients with Metastatic, Well-Differentiated Neuroendocrine Tumors: A Prospective Study
Autor: Wenjia Zhu, a další
Vydáno: (2019)

Localization of Hidden Insulinomas with <sup>68</sup>Ga-DOTA-Exendin-4 PET/CT: A Pilot Study
Autor: Kwadwo Antwi, a další
Vydáno: (2015)

Comprehensive Quality Control of the ITG <sup>68</sup>Ge/<sup>68</sup>Ga Generator and Synthesis of <sup>68</sup>Ga-DOTATOC and <sup>68</sup>Ga-PSMA-HBED-CC for Clinical Imaging
Autor: Alejandro Amor‐Coarasa, a další
Vydáno: (2016)

Comparison of Early Imaging and Imaging 60 min Post-Injection after Forced Diuresis with Furosemide in the Assessment of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for 68Ga-PSMA-11 PET/CT
Autor: Bayerschmidt, Steffen, a další
Vydáno: (2021)

<sup>68</sup>Ga-DOTA-FAPI-04 PET/MR in the Evaluation of Gastric Carcinomas: Comparison with <sup>18</sup>F-FDG PET/CT
Autor: Chunxia Qin, a další
Vydáno: (2021)

Site-specific stabilization of minigastrin analogs against enzymatic degradation for enhanced cholecystokinin-2 receptor targeting
Autor: Klingler, Maximilian, a další
Vydáno: (2018)

Preclinical Comparative Study of <sup>68</sup>Ga-Labeled DOTA, NOTA, and HBED-CC Chelated Radiotracers for Targeting PSMA
Autor: Sangeeta Ray Banerjee, a další
Vydáno: (2016)

Exploiting the Concept of Multivalency with (68)Ga- and (89)Zr-Labelled Fusarinine C-Minigastrin Bioconjugates for Targeting CCK2R Expression
Autor: Summer, Dominik, a další
Vydáno: (2018)

Repetitive Early<sup>68</sup>Ga-FAPI PET Acquisition Comparing<sup>68</sup>Ga-FAPI-02,<sup>68</sup>Ga-FAPI-46, and<sup>68</sup>Ga-FAPI-74: Methodologic and Diagnostic Implications for Malignant, Inflammatory/Reactive, and Degenerative Lesions
Autor: Frederik M. Glatting, a další
Vydáno: (2022)

Site-specific stabilization of minigastrin analogs against enzymatic degradation for enhanced cholecystokinin-2 receptor targeting: Erratum
Autor: Klingler, Maximilian, a další
Vydáno: (2019)

<sup>68</sup> Ga-DOTA-GGNle-CycMSH <sub>hex</sub> targets the melanocortin-1 receptor for melanoma imaging
Autor: Jianquan Yang, a další
Vydáno: (2018)

Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m
Autor: Klingler, Maximilian, a další
Vydáno: (2019)

<sup>68</sup>Ga-Labeled Fibroblast Activation Protein Inhibitor (<sup>68</sup>Ga-FAPI) PET for Pancreatic Adenocarcinoma: Data from the<sup>68</sup>Ga-FAPI PET Observational Trial
Autor: Lukas Kessler, a další
Vydáno: (2023)

<sup>68</sup>Ga-DOTATOC Versus <sup>68</sup>Ga-DOTATATE PET/CT in Functional Imaging of Neuroendocrine Tumors
Autor: Thorsten D. Poeppel, a další
Vydáno: (2011)

Comparative Biodistribution and Radiation Dosimetry of <sup>68</sup>Ga-DOTATOC and <sup>68</sup>Ga-DOTATATE in Patients with Neuroendocrine Tumors
Autor: Mattias Sandström, a další
Vydáno: (2013)

Prospective of <sup>68</sup>Ga-Radiopharmaceutical Development
Autor: Irina Velikyan
Vydáno: (2014)

Comparison of <sup>68</sup>Ga-DOTANOC and <sup>68</sup>Ga-DOTATATE PET/CT Within Patients with Gastroenteropancreatic Neuroendocrine Tumors
Autor: Damian Wild, a další
Vydáno: (2013)

Quantitative and Qualitative Intrapatient Comparison of <sup>68</sup>Ga-DOTATOC and <sup>68</sup>Ga-DOTATATE: Net Uptake Rate for Accurate Quantification
Autor: Irina Velikyan, a další
Vydáno: (2013)

Ethanol-Based Post-processing of Generator-Derived <sup>68</sup>Ga Toward Kit-Type Preparation of <sup>68</sup>Ga-Radiopharmaceuticals
Autor: Elisabeth Eppard, a další
Vydáno: (2014)

<sup>68</sup>Ga or<sup>18</sup>F for Prostate Cancer Imaging?
Autor: Claudia Kesch, a další
Vydáno: (2017)

Performance of <sup>68</sup>Ga-DOTA–Conjugated Somatostatin Receptor–Targeting Peptide PET in Detection of Pheochromocytoma and Paraganglioma: A Systematic Review and Metaanalysis
Autor: Sangwon Han, a další
Vydáno: (2018)

Functional imaging of neuroendocrine tumors with combined PET/CT using <sup>68</sup>Ga‐DOTATATE (DOTA‐<scp>D</scp>Phe<sup>1</sup>,Tyr<sup>3</sup>‐octreotate) and <sup>18</sup>F‐FDG
Autor: Irfan Kayani, a další
Vydáno: (2008)

Measured Human Dosimetry of<sup>68</sup>Ga-DOTATATE
Autor: Ronald C. Walker, a další
Vydáno: (2013)

<sup>68</sup>Ga-FAPI as a Diagnostic Tool in Sarcoma: Data from the <sup>68</sup>Ga-FAPI PET Prospective Observational Trial
Autor: Lukas Kessler, a další
Vydáno: (2021)

Evaluation of <sup>68</sup>Ga- and <sup>177</sup>Lu-DOTA-PEG<sub>4</sub>-LLP2A for VLA-4-Targeted PET Imaging and Treatment of Metastatic Melanoma
Autor: Wissam Beaino, a další
Vydáno: (2015)